137 related articles for article (PubMed ID: 2543085)
61. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
Basson J; Tardy JC; Aymard M
J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
[TBL] [Abstract][Full Text] [Related]
62. Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases.
Kim SA; Lee SI; Choi IH; Shin JS; Uhm JR; Kim SJ; Choi HJ
Yonsei Med J; 1990 Dec; 31(4):347-58. PubMed ID: 2150250
[TBL] [Abstract][Full Text] [Related]
63. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
64. Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells.
Dienstag JL; Savarese AM; Cohen RB; Bhan AK
Clin Exp Immunol; 1982 Oct; 50(1):7-16. PubMed ID: 6217002
[TBL] [Abstract][Full Text] [Related]
65. Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A.
Ray PK
Contemp Top Immunobiol; 1985; 15():147-211. PubMed ID: 3161699
[TBL] [Abstract][Full Text] [Related]
66. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
67. Immunoabsorption in an extracorporeal plasma perfusion system: in vitro studies.
Burgstaler EA; Pineda AA
Artif Organs; 1981 Aug; 5(3):259-63. PubMed ID: 7030281
[TBL] [Abstract][Full Text] [Related]
68. Immunoadsorption of human plasma with protein A-sepharose columns.
Branda RF; Miller WJ; Soltis RD; McCullough JJ
Transfusion; 1986; 26(5):471-7. PubMed ID: 3532448
[TBL] [Abstract][Full Text] [Related]
69. Ex vivo removal of serum IgG in a patient with colon carcinoma: some biochemical, immunological and histological observations.
Bansal SC; Bansal BR; Thomas HL; Siegel PD; Rhoads JE; Cooper DR; Terman DS; Mark R
Cancer; 1978 Jul; 42(1):1-18. PubMed ID: 352503
[TBL] [Abstract][Full Text] [Related]
70. A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption.
Hartmann C; Bloedow DC; Dienhart DG; Kasliwal R; Johnson TK; Gonzalez R; Bunn PA
J Pharmacokinet Biopharm; 1991 Aug; 19(4):385-403. PubMed ID: 1920086
[TBL] [Abstract][Full Text] [Related]
71. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
72. Structural characteristics of circulating immune complexes in calves with bronchopneumonia: Impact on the quiescent leukocytes.
Kovačić M; Fratrić N; Arsić A; Mojsilović S; Drvenica I; Marković D; Maslovarić I; Grujić Milanović J; Ivanov M; Ilić V
Res Vet Sci; 2020 Dec; 133():63-74. PubMed ID: 32942254
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract][Full Text] [Related]
74. Therapeutic plasmapheresis and protein A immunoadsorption in malignancy: a brief review.
Nand S; Molokie R
J Clin Apher; 1990; 5(4):206-12. PubMed ID: 2229001
[TBL] [Abstract][Full Text] [Related]
75. Enzyme therapy and immuno-adsorption by an extra-corporeal device.
Hydén H
Biomater Med Devices Artif Organs; 1980; 8(1):1-11. PubMed ID: 6988019
[TBL] [Abstract][Full Text] [Related]
76. Adverse clinical effects of immune sorption with staphylococcal protein A columns.
Huestis DW; Morrison FS
Transfus Med Rev; 1996 Jan; 10(1):62-70. PubMed ID: 8787931
[No Abstract] [Full Text] [Related]
77. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications.
Fuchs K; Rummler S; Ries W; Helmschrott M; Selbach J; Ernst F; Morath C; Gauly A; Atiye S; Stauss-Grabo M; Giefer M
Ther Apher Dial; 2022 Feb; 26(1):229-241. PubMed ID: 33914397
[TBL] [Abstract][Full Text] [Related]
78. Immunoadsorption in systemic connective tissue diseases and primary vasculitis.
Schneider M; Gaubitz M; Perniok A
Ther Apher; 1997 May; 1(2):117-20. PubMed ID: 10225754
[TBL] [Abstract][Full Text] [Related]
79. An unexpected complication following immunoadsorption with a staphylococcal protein A column.
Huestis DW; Rifkin RM; Durie BG; Sibley WA; Irani M
J Clin Apher; 1992; 7(2):75-7. PubMed ID: 1429491
[TBL] [Abstract][Full Text] [Related]
80. Apheresis of immune diseases and apheresis using immunological specificity.
Yagihashi A; Kikuchi K
Ther Apher; 2002 Oct; 6(5):358-64. PubMed ID: 12423530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
